0 Σχόλια
0 Μοιράστηκε
1χλμ. Views
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Ροή Δημοσιεύσεων
- ΑΝΑΚΆΛΥΨΕ
-
Σελίδες
-
Ομάδες
-
Blogs
-
Forum
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Noonan Syndrome Market: How Are MEK Inhibitors and Next-Gen Growth Hormones Reshaping Treatment for This RASopathy?MEK inhibitor breakthroughs in Noonan syndrome — the targeted MAPK pathway therapies demonstrating cardiac function improvement in children with severe hypertrophic cardiomyopathy, alongside Novo Nordisk's February 2026 FDA approval of once-weekly Sogroya (somapacitan) for Noonan-associated growth failure — represent the most transformative therapeutic innovations in this...0 Σχόλια 0 Μοιράστηκε 10 Views
-
Noonan Syndrome Market: How Is Adult Transition Care Addressing the Previously Neglected Older Patient Population?Adult transition care in Noonan syndrome — the emerging medical subspecialty addressing the aging RASopathy population historically focused on pediatric management, representing the most demographically significant market expansion in the Noonan Syndrome Market — creates the most underserved clinical segment, with adult patients experiencing continued medical needs and previously...0 Σχόλια 0 Μοιράστηκε 10 Views